CAMBRIDGE, Mass., June 16 /PRNewswire-FirstCall/ -- Vertex
Pharmaceuticals Incorporated (Nasdaq: VRTX) will webcast its corporate
presentations at NASDAQ's 17th Investor Program on Wednesday, June 21, 2006
at 2:45 p.m. British Summer Time (BST) (9:45 a.m. EDT) and at the Piper
Jaffray London Healthcare Conference on Thursday, June 22, 2006 at 9:20
a.m. BST (4:20 a.m. EDT). The presentations will be delivered by John Alam,
M.D., Executive Vice President, Medicines Development and Chief Medical
Officer of Vertex.
The presentations will be webcast live and may be accessed by visiting
the Vertex website at http://www.vrtx.com. A replay of the webcasts will
also be available on the Company's website for two weeks following the
presentations. To access the webcasts, go to Vertex's website and select
the 'NASDAQ 17th Annual Investor Program' or the 'Piper Jaffray London
Healthcare Conference' from the 'Events & Presentations' page. To ensure a
timely connection, it is recommended that users register at least 15
minutes prior to the scheduled webcast.
About Vertex
Vertex Pharmaceuticals Incorporated is a global biotechnology company
committed to the discovery and development of breakthrough small molecule
drugs for serious diseases. The Company's strategy is to commercialize its
products both independently and in collaboration with major pharmaceutical
companies. Vertex's product pipeline is principally focused on viral
diseases, inflammation, autoimmune diseases and cancer. In collaboration
with GlaxoSmithKline, Vertex co-promotes the HIV protease inhibitor,
Lexiva.
Lexiva is a registered trademark of the GlaxoSmithKline group of
companies.
Vertex's press releases are available at http://www.vrtx.com.
Vertex Contact:
Lora Pike, Manager, Investor Relations, (617) 444-6755
SOURCE Vertex Pharmaceuticals Incorporated
 back to top
Related links:
http://www.vrtx.com/
http://www.prnewswire.com/comp/938395.html/
CONTACT:
Lora Pike, Manager, Investor Relations of
Vertex, +1-617-444-6755
|
